Inhibitory Control: Effects of Modulation
Launched by BUTLER HOSPITAL · Jan 28, 2020
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
**Clinical Trial Summary: Inhibitory Control: Effects of Modulation**
This clinical trial is looking at how certain brain networks involved in controlling our impulses work in healthy young adults. Impulse control is important for managing various conditions like substance abuse, obsessive-compulsive disorder, and attention-deficit hyperactivity disorder. The researchers aim to use a technique called neuromodulation to see if they can improve how these brain networks function and, in turn, enhance performance on tasks that require good impulse control. By understanding these brain mechanisms better, the hope is to improve treatments for people who struggle with impulse control issues.
If you are a healthy young adult aged 18 to 35 and are fluent in English, you might be eligible to participate in this study. Participants will be grouped based on their impulse control abilities, as measured by a specific test. However, if you have certain medical conditions, a history of seizures, or are currently taking psychiatric medications, you may not be able to join. Those who participate can expect to undergo various assessments, including an MRI, and to engage in tasks designed to test their impulse control. This study could contribute to meaningful advancements in how we treat impulse control disorders in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Low (\<1sd below the mean on the BRIEF-Inhibit) or high (\>1sd above the mean on BRIEF-Inhibit scale)
- • 2. English fluency to ensure comprehension of study measures and instructions.
- Exclusion Criteria:
- • 1. Presence of medical conditions contraindicated for tDCS, including history of any known intracranial pathology, epilepsy or seizures, traumatic brain injury, brain tumor, stroke, implanted medical devices, current pregnancy or women of childbearing age not using effective contraception, or any other serious medical conditions or health problems that would interfere with participation (e.g., skin condition)
- • 2. Inability to undergo MRI
- • 3. Current substance abuse disorder
- • 4. Currently prescribed psychiatric medications.
- • 5. Active mania or psychosis
About Butler Hospital
Butler Hospital is a leading psychiatric and behavioral health facility dedicated to advancing mental health care through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital focuses on developing and evaluating new therapeutic interventions, aiming to improve treatment outcomes for patients with various mental health conditions. With a commitment to evidence-based practice, Butler Hospital collaborates with a multidisciplinary team of experts to ensure rigorous methodology and ethical standards in all research endeavors, ultimately enhancing the quality of care for individuals in need.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Providence, Rhode Island, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials